As reported by several authors, the frequency of mutations in the RAS gene (mainly K-RAS) is about 30% of all cancer types [72] and is present in 10% of all patients with cancer [73]; RAF mutations (particularly B-RAF) have been identified in about 8% of all cancer types [74]. Here, KRAS is linked to cancer.